At-home health test maker Thorne explores sale | Reuters News Agency

[ad_1]

Business & FinanceDealsHealth

Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. 

Market Impact

Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million. They are up 63.9% year-to-date, outperforming an 18.2% rise in the S&P 500 Index.

Article Tags

Topics of Interest: Business & FinanceDealsHealth

Type: Reuters Best

Sectors: Business & FinancePharmaceuticals & Healthcare

Regions: Americas

Countries: United States

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *